Huang M X
School of Stomatology, Beijing Medical University.
Zhonghua Kou Qiang Yi Xue Za Zhi. 1993 Sep;28(5):289-91, 319.
This paper reports 5 patients with MFH in the soft tissues and 10 in the jaws. Fourteen patients (5 in soft tissues and 9 in jaws) underwent surgery, 5 and 3 of the 9 bone cases received additional irradiation and chemotherapy respectively. Fourteen patients had been followed up for 6 months to 4 and 1/2 years. Two patients of jaw had local recurrences 1 to 8 months following surgery; 6 of 9 ones with follow-up died, 2 of whom were associated with pulmonary metastases. MFH of bone showed significantly worse prognosis than those localized in soft tissues, particularly in maxilla. Pathologically, the tumors of this series were divided into 5 types. The relation between the mitosis and the malignancy of MFH in the jaws was significant. Immunohistochemical stains for lysozyme, A, AT and ACT showed that ACT was the most sensitive marker for MFH.
本文报告了5例软组织恶性纤维组织细胞瘤患者和10例颌骨恶性纤维组织细胞瘤患者。14例患者(5例软组织患者和9例颌骨患者)接受了手术,9例骨病例中的5例和3例分别接受了额外的放疗和化疗。14例患者随访了6个月至4年半。2例颌骨患者术后1至8个月出现局部复发;9例接受随访的患者中有6例死亡,其中2例伴有肺转移。骨恶性纤维组织细胞瘤的预后明显比软组织恶性纤维组织细胞瘤差,尤其是在上颌骨。病理上,本系列肿瘤分为5型。颌骨恶性纤维组织细胞瘤的有丝分裂与恶性程度之间存在显著关系。溶菌酶、A、AT和ACT的免疫组化染色显示,ACT是恶性纤维组织细胞瘤最敏感的标志物。